Radical radiotherapy treatment (EBRT + HDR-ICRT) of carcinoma of the uterine cervix: Outcome in patients treated at a rural center in India

Journal of Cancer Research and Therapeutics

Volumn 3, Issue 4, 2007, Pages 211-217

  Jain, Vandana S ^a,b   Singh, Kailash K ^a   Shrivastava, Rajeev ^a   Saumsundaram, K V ^a   Sarje, Mukund B ^a   Jain, Shailendra M ^a  

^a Pravara Rural University   (India)

^b Department of Radiotherapy   (India)

Author keywords

Carcinoma cervix; High dose rate brachytherapy; Radiotherapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HIGH DOSE RATE INTRACAVITARY RADIOTHERAPY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OUTCOMES RESEARCH; RADIATION INJURY; RETROSPECTIVE STUDY; RURAL AREA; UTERINE CERVIX CANCER;

EID: 39349101386     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.38996     Document Type: Article

References (22)

1. Saibishkumar EP, Patel FD, Sharma SC. Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: An audit from India. Clin Oncol (R Coll Radiol) 2006;18:30-7.
2. Tan LT, Orton CJ, Blake PR, Jones B. Gynaecological brachytherapy: A 1 day seminar organized by the British Institute of Radiology Brachytherapy Working Paty. Br J Radiol 2004;77:1-2.
3. Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000;48:201-11.
4. Foroudi F, Bull CA, Gebski V. Radiation therapy for cervix carcinoma: Benefits of individualized dosimetry. Clin Oncol (R Coll Radiol) 2002;14:43-9.
5. Sunder S, Symonds P, Deehan C. Tolerance of pelvic organs to radiation treatment for carcinoma of cervix. Clin Oncol (R Coll Radiol) 2003;15:240-7.
6. King M, McConkey C, Latief TN, Hartley A, Fernando I. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side effects. Clin Oncol (R Coll Radiol) 2006;18:38-45.
7. Lorvidhaya V, Tonusin A, Changwiwit W, Chitapanarux I, Srisomboon J, Wanwilairat S, et al. High dose rate after loading brachytherapy in carcinoma of the cervix: An experience of 1992 patients. Int J Radiat Oncol Biol Phys 2000;46:1185-91.
8. Arai T, Nakano T, Morita S, Sakashita K, Nakamura YK, Fukuhisa K. High dose rate remote after loading intracavitary radiation therapy for cancer of the uterine cervix. Cancer 1992;69:175-80.
9. Chen SW, Liang JA, Yeh LS, Yang SN, Shiau AC, Lin FJ. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2004;60:663-71.
10. Kapp KS, Stuecklschweiger GF, Kapp DS, Poschauko J, Pickel H, Lahousen M, et al. Prognostic factors in patiets with carcinoma of the uterine cervix treated with external beam irradiation and IR-92 high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1998;42:531-40.
11. Annual report on the results of treatment on the gynecological cancer. In: Patterson F, editor. Twentieth volume statements of results obtained in patients treated in 1979-1981, inclusive 5year survival up to 1986. International Federation of Gynecology and Obstetrics: Stockholm; 1987. p. 52.
12. Eilic S, Ristic B. Five result with HDR after loading in cervix cancer: Dependence on fractionation and dose. Strahlenther Onkol 1988;82:139-46.
13. Ito H, Kutuki S, Nishiguchi I, Shigematsu N, Kuribayashi T, Uematsu M, et al. Radiotherapy for cervical cancer with high-dose rate brachytherapy, correlation between tumor size, dose and failure. Radiother Oncol 1994;31:240-7.
14. Joslin CA. High-activity source after loading in gynecologic cancer and its future prospects. Endocurie Ther Hyperther Oncol 1989;5:69-82.
15. Macleod C, Fowler A, Darymple C, D'Costa I, Firth I, Atkinson K, et al. High dose rate brachytherapy in management of carcinoma of the cervix: An 8-year Australian experience. Aust N Z J Obstet Gynaecol 1997;37:342-7.
16. Patel FD, Sharma SC, Negi PS, Ghoshal S, Gupta BD. Low dose rate vs. high dose rate brachytherapy in treatment of carcinoma of the uterine cervix: A clinical trial. Int J Radiat Oncol Biol Phys 1994;28:335-41.
17. Shelke P, Roman TN, Souhami L, Freeman CR, Clark BG, Evans MD, et al. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993;27:803-9.
18. Saibishkumar EP, Patel FD, Sharma SC, Karunanidhi G, Sankar AS, Mallick I. Results of external beam radiotherapy alone in invasive cancer of the uterine cervix: A retrospective analyses. Clin Oncol (R Coll Radiol) 2006;18:46-51.
19. King M, McConkey C, Latief TN, Hartley A, Fernando I. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. Clin Oncol (R Coll Radiol) 2006;18:38-45.
20. Greek JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta analyses. Lancet 2001;358:781-6.
21. Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, et al. Clinical application of Intesity- modulated radiotherapy for locally advanced radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002;12:260-71.
22. Jain VS, Singh KK. Significance of preoperative diagnosis and staging in carcinoma cervix. Obstet Gynaecol Today 2006;11:517-9.